Senior U.S. Health & Science Correspondent, 3 Times Square
Sharon's Feed
Oct 18, 2014
Oct 17, 2014

Analysis – U.S. health agency chief faulted over confusing Ebola messages

NEW YORK (Reuters) – The widening circle of people potentially exposed to Ebola in the United States is calling into question how well Dr. Thomas Frieden, the lead U.S. public health advisor, has communicated the risks of the deadly virus, according to crisis management and infectious disease experts.

    When the first diagnosis of Ebola on U.S. soil was confirmed on Sept. 30, Frieden, director of the U.S. Centers for Disease Control and Prevention (CDC), clearly stated that additional cases were possible among contacts of the patient, Liberian Thomas Eric Duncan. Two nurses who cared for Duncan in Dallas have since been diagnosed with the disease.

Oct 17, 2014

U.S. health agency chief faulted over confusing Ebola messages

NEW YORK (Reuters) – The widening circle of people potentially exposed to Ebola in the United States is calling into question how well Dr. Thomas Frieden, the lead U.S. public health advisor, has communicated the risks of the deadly virus, according to crisis management and infectious disease experts.

When the first diagnosis of Ebola on U.S. soil was confirmed on Sept. 30, Frieden, director of the U.S. Centers for Disease Control and Prevention (CDC), clearly stated that additional cases were possible among contacts of the patient, Liberian Thomas Eric Duncan. Two nurses who cared for Duncan in Dallas have since been diagnosed with the disease.

Oct 17, 2014

Exclusive: U.S. requests production plans for Ebola drug ZMapp

NEW YORK/WASHINGTON (Reuters) – U.S. health officials have asked three advanced biology laboratories to submit plans for producing the experimental Ebola drug ZMapp, which ran out after it was given to a handful of medical workers who contracted the disease in West Africa, government and lab officials said on Friday.

Under the “task order” issued on Thursday by the Biomedical Advanced Research and Development Authority (BARDA), a state-of-the-art manufacturing center in Texas will submit plans for manufacturing ZMapp, said Dr. Brett Giroir, chief executive officer of Texas A&M Health Science Center, which houses the lab. The lab works in conjunction with Britain’s GlaxoSmithKline Plc.

Oct 17, 2014
Oct 16, 2014
Oct 16, 2014
Oct 16, 2014
Oct 15, 2014
Oct 15, 2014
    • About Sharon

      "After covering science and medicine at Newsweek, then the Wall Street Journal, then Newsweek again, I joined Reuters in 2012 to report on neuroscience, genetics, cognitive science, and other research. My books have focused on the brain: 2007's Train Your Mind, Change Your Brain (the first popular account of the revolution in neuroplasticity), and 2012's The Emotional Life of Your Brain (with Richard J. Davidson)."
      Joined Reuters:
      2012
      Languages:
      English
    • More from Sharon

      Publications:
      The Emotional Life of Your Brain (2012)
      Train Your Mind, Change Your Brain (2007)
      The Mind and the Brain (2002)
    • Contact Sharon

    • Follow Sharon